By Mr Alexander Lewis Dowell-Day

Journal articles

Arapali T; Warzywoda S; Smith AKJ; Chan C; Broady TR; Sullivan E; MacPhail C; Hammoud MA; Dowell-Day A; Bavinton BR, 2025, 'Differentiated and simplified oral HIV pre‐exposure prophylaxis PrEP models hold the key to virtually eliminating HIV transmission in Australia by 2030', Medical Journal of Australia, 223, pp. 556 - 559, http://dx.doi.org/10.5694/mja2.70097

Wells N; Richman B; Grace D; Riley B; Hui C; Vojnov L; Stackpool-Moore L; Ong JJ; Dowell-Day A; Allan B, 2024, '2023 Undetectable = Untransmittable global policy roundtable report: a multistakeholder perspective on Undetectable = Untransmittable research and policy priorities', Sexual Health, 21, pp. SH24017, http://dx.doi.org/10.1071/sh24017

Dowell-Day A; Dobbins T; Chan C; Fraser D; Holt M; Vaccher SJ; Clifton B; Zablotska I; Grulich A; Bavinton BR, 2023, 'Attitudes Towards Treatment as Prevention Among PrEP-Experienced Gay and Bisexual Men in Australia', AIDS and Behavior, 27, pp. 2969 - 2978, http://dx.doi.org/10.1007/s10461-023-04019-x

Grebely J; Tran L; Degenhardt L; Dowell-Day A; Santo T; Larney S; Hickman M; Vickerman P; French C; Butler K; Gibbs D; Valerio H; Read P; Dore GJ; Hajarizadeh B, 2021, 'Association between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection among People Who Inject Drugs: A Systematic Review and Meta-analysis', Clinical Infectious Diseases, 73, pp. E107 - E118, http://dx.doi.org/10.1093/cid/ciaa612

Seale H; Dyer CEF; Abdi I; Rahman KM; Sun Y; Qureshi MO; Dowell-Day A; Sward J; Islam MS, 2020, 'Improving the impact of non-pharmaceutical interventions during COVID-19: Examining the factors that influence engagement and the impact on individuals', BMC Infectious Diseases, 20, http://dx.doi.org/10.1186/s12879-020-05340-9

Conference Presentations

Smith AKJ; Brener L; Broady T; Bavinton B; Keen P; Costello J; Heslop A; Hammoud M; Wells N; Murphy D; Saliba B; Dowell-Day A; Varma R; Watson L; Delpech V; Prain B; Treloar C; On behalf of the NSW HIV PRISM Partnership , 2025, 'Untransmittable scepticism and stigma: understanding gay and bisexual men’s perspectives towards sexual partners living with HIV', presented at Australasian HIV&AIDS Conference, Adelaide, 15 September 2025 - 17 September 2025, http://dx.doi.org/10.26190/unsworks/31735

Arapali T; Keen P; Varma R; Smith AKJ; Hammoud M; Warzywoda S; Dowell-Day A; Bavinton B, 2024, 'HIV pre-exposure prophylaxis (PrEP) access in the modern age: a narrative review of PrEP telehealth models and their implementation considerations', presented at 13th Health Services Research Conference, Sydney, NSW, 04 December 2024 - 06 December 2024, https://airdrive.eventsair.com/eventsairaueprod/production-eventstudio-public/ebef5f0a2f3947f6bd3dd3919b3e4e72

Reports

Keen P; Dowell-Day A; Gordon T; Bavinton BR; Molyneux A; Grulich AE, 2025, Awareness and experiences of contemporary options for HIV testing among untested and under-tested gay and bisexual men: research to inform targeted promotion of HIV testing to address increased late HIV diagnoses in NSW, Kirby Institute, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/unsworks/31295

Arapali T; Warzywoda S; Smith AKJ; Keen P; Mac Phail C; Dowell-Day A; Clackett S; Sullivan E; Chan C; Hammoud MA; Holt M; Avasalu R; Grulich A; Bavinton B, 2024, Innovative oral PrEP service delivery models and the policy, legal, and regulatory barriers to their implementation, http://dx.doi.org/10.26190/4xvf-0083

Back to profile page